Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Thiamine Supplementation in High Risk Cardiac Surgery Patients

NCT03306732 is registered in ClinicalTrials.gov with Meshalkin Research Institute of Pathology of Circulation as lead sponsor.

NCT NCT03306732
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03306732 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Thiamine Supplementation in High Risk Cardiac Surgery Patients
Lead sponsor
Meshalkin Research Institute of Pathology of Circulation
Phase
Phase 4
Overall status
Completed
Start date
October 19, 2017
Completion date
June 18, 2018
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac surgery